PORTAGE BIOTECH INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2431 USD | -6.50% |
|
+0.21% | -86.64% |
| 04-15 | Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives | CI |
| 04-12 | Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives | CI |
Chart calendar Portage Biotech Inc.
82.gYYq8hWHfTPQYT80oBv8jBXC5Op_DE4UbEKYrJSuFjk.ufd4o1H_CAeBVkVj00LJx1ObstMRfiNSIC7K66LhWG3jy2WAJ9EfcKYjUA~d73a15be9ae27ac6d22b2413e695e9d7
Upcoming events on Portage Biotech Inc.
Past events on Portage Biotech Inc.
| 28/02/2024 22:10 | Q3 2024 Earnings Release |
| 28/11/2023 21:01 | Q2 2024 Earnings Release |
| 28/09/2023 15:20 | Cantor Global Healthcare Conference |
| 11/09/2023 | H.C. Wainwright Global Investment Conference |
| 30/08/2023 13:00 | Q1 2024 Earnings Release |
| 31/07/2023 21:05 | Q4 2023 Earnings Release |
| 08/06/2023 15:15 | BIO International Convention - Panel |
| 14/03/2023 18:00 | Oppenheimer Healthcare Conference |
| 09/03/2023 15:30 | Investor Meeting - Key Opinion Leader |
| 01/03/2023 13:00 | Q3 2023 Earnings Release |
| 22/02/2023 14:00 | Citi Virtual Oncology Leadership Summit |
| 29/11/2022 21:43 | Interim 2023 Earnings Release |
| 10/11/2022 15:30 | Annual General Meeting |
| 10/11/2022 14:00 | Society for Immunotherapy of Cancer Meeting - Abstract No. - 745 |
| 29/08/2022 13:00 | Q1 2023 Earnings Release |
| 01/08/2022 13:00 | FY 2022 Earnings Release |
| 07/07/2022 13:30 | Acquisition of Tarus Therapeutics by Portage Biotech, Inc Call |
| 05/06/2022 | American Society of Clinical Oncology Meeting - Abstract Number: 2520 |
| 05/06/2022 | American Society of Clinical Oncology Meeting - Abstract Number: 11515 |
| 05/06/2022 | American Society of Clinical Oncology Meeting - Abstract Number: 382017 |
Annual results
| Fiscal Period | Maart | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -15,6 -15,3 -1.84% | -16,6 -18,0 7.92% | -19,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,8 -15,1 2.19% | -123 -18,0 -580.68% | -62,4 |
|
Net income Million USD | Released Forecast Spread | -16,9 -13,7 -22.75% | -105 -16,0 -553.82% | -51,8 |
|
EPS USD | Released Forecast Spread | -1,29 -1,05 -22.86% | -6,49 -0,94 -590.43% | -2,72 |
| Announcement Date | 01/08/22 | 31/07/23 | - |
Quarterly results
| Fiscal Period | Maart | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -4,17 -3,60 -15.81% | -4,50 -4,24 -6% | -4,09 -4,38 6.67% | -3,65 -4,20 13.04% | -4,76 -3,88 -22.75% | -4,08 -5,00 18.48% | -5,00 -4,18 -19.62% | -5,93 -4,63 -27.99% | -4,03 -5,84 31.06% | -4,40 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,09 -4,00 -2.23% | -4,05 -4,26 5.08% | -4,18 -4,35 3.87% | -3,64 -4,53 19.77% | -5,30 -3,88 -36.76% | -109 -5,00 -2088.1% | -6,07 -4,18 -45.33% | -6,07 -4,63 -31.06% | -48,9 -5,82 -740.07% | -4,35 |
|
Net income Million USD | Released Forecast Spread | -3,51 -3,78 7.04% | -7,32 -3,78 -93.83% | -1,73 -4,05 57.26% | -0,95 -4,53 79.07% | -7,49 -3,88 -93.06% | -94,4 -5,00 -1788.96% | -5,92 -4,18 -41.69% | -5,16 -4,63 -11.33% | -39,4 -5,82 -576.74% | -4,35 |
|
EPS USD | Released Forecast Spread | -0,26 -0,27 4.88% | -0,55 -0,28 -98.79% | -0,13 -0,30 56.18% | -0,06 -0,29 79.31% | -0,44 -0,23 -95.56% | -6,00 -0,27 -2122.22% | -0,33 -0,24 -37.5% | -0,29 -0,27 -7.41% | -1,88 -0,27 -596.3% | -0,22 |
| Announcement Date | 24/02/22 | 01/08/22 | 29/08/22 | 29/11/22 | 01/03/23 | 31/07/23 | 29/08/23 | 28/11/23 | 28/02/24 | - |
| 01/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | INTELLIA THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | MODERNA, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
Past sector events for Portage Biotech Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PRTG Stock
- Calendar Portage Biotech Inc.
